1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015

Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Respiratory Distress Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Respiratory Distress Syndrome 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Respiratory Distress Syndrome Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Respiratory Distress Syndrome 35
May 14, 2015: Discovery Labs Announces Results of Phase 2a Clinical Trial of AEROSURF 35
Apr 29, 2015: Serendex Initiates Phase I Clinical Trial For Lead Candidate Drug, Molgradex 35
Apr 16, 2015: Discovery Labs Completes Enrollment of AEROSURF Phase 2a Clinical Trial and Restructures its Business to Focus on Development of AEROSURF and Aerosolized KL4 Surfactant Pipeline 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Discovery Laboratories, Inc. 37
Clinical Trial Overview of Discovery Laboratories, Inc. 37
Chiesi Farmaceutici SpA 38
Clinical Trial Overview of Chiesi Farmaceutici SpA 38
Ikaria Holdings, Inc. 39
Clinical Trial Overview of Ikaria Holdings, Inc. 39
GlaxoSmithKline Plc 40
Clinical Trial Overview of GlaxoSmithKline Plc 40
Serendex Pharmaceuticals A/S 41
Clinical Trial Overview of Serendex Pharmaceuticals A/S 41
Pierrel S.p.A. 42
Clinical Trial Overview of Pierrel S.p.A. 42
Forest Laboratories, Inc. (Inactive) 43
Clinical Trial Overview of Forest Laboratories, Inc. (Inactive) 43
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
Abbott Laboratories 45
Clinical Trial Overview of Abbott Laboratories 45
Actelion Ltd 46
Clinical Trial Overview of Actelion Ltd 46
Clinical Trial Overview of Top Institutes / Government 47
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
Tabriz University of Medical Sciences 49
Clinical Trial Overview of Tabriz University of Medical Sciences 49
Eunice Kennedy Shriver National Institute of Child Health and Human Development 50
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 50
University of Oklahoma 51
Clinical Trial Overview of University of Oklahoma 51
Aga Khan University 52
Clinical Trial Overview of Aga Khan University 52
Asan Medical Center 53
Clinical Trial Overview of Asan Medical Center 53
Assistance Publique Hopitaux De Marseille 54
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 54
Auckland City Hospital 55
Clinical Trial Overview of Auckland City Hospital 55
Centre Hospitalier Universitaire de Clermont-Ferrand 56
Clinical Trial Overview of Centre Hospitalier Universitaire de Clermont-Ferrand 56
Dr. Sami Ulus Children's Hospital 57
Clinical Trial Overview of Dr. Sami Ulus Children's Hospital 57
Five Key Clinical Profiles 58
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 87

List of Tables
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Respiratory Distress Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Respiratory Distress Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Respiratory Distress Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Discovery Laboratories, Inc., 2015* 37
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2015* 38
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015* 39
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 40
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Serendex Pharmaceuticals A/S, 2015* 41
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierrel S.p.A., 2015* 42
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc. (Inactive), 2015* 43
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 44
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015* 46
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 47
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 49
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 50
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2015* 51
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015* 52
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 53
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015* 54
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland City Hospital, 2015* 55
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Clermont-Ferrand, 2015* 56
Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Sami Ulus Children's Hospital, 2015* 57

List of Figures
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.